EXPRESSION OF Toll-LIKE RECEPTORS IN SPLEEN AND LYMPHATIC NODES AFTER IMMUNIZATION BY MUCOSAL ROUTES


Cite item

Full Text

Abstract

Aim. To determine level of Toll-like receptors (TLRs) expression in spleen and lymphatic nodes of mice after immunization by mucosal routes. Materials and methods. Mice were immunized with polycomponent vaccine Immunovac ® either by mucosal or subcutaneous route. Expression of TLRs in spleen, respiratory tract-associated lymphatic nodes as well as in small intestine was measured in immunized mice by flow cytomentry method. Results. After immunization of mice by subcutaneous, intranasal and oral routes level of TLRs expression was different. Significant expression of TLR9 and absence of TLR2 expression was noted after non-parenteral methods of immunization. After oral immunization expression of TLRs was identified in gut- and respiratory tract-associated lymphoid tissue as well as in spleen; after intranasal immunization – in respiratory tract-associated lymphoid tissue, and after subcutaneous immunization — in spleen and respiratory tract-associated lymphoid tissue. Conclusion. After oral immunization expression of TLRs was identified in all studied organs, including spleen. Involvement of spleen to this process allows to assume establishment of not only local but also systemic immunity.

About the authors

N. K Akhmatova

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

N. B Egorova

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

E. A Akhmatov

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

E. A Kurbatova

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

I. B Semenova

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

I. V Chertov

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

B. F Semenov

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

V. V Zverev

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

References

  1. А хматова Н.К., Киселевский М.В. Врожденный иммунитет: противоопухолевый и противоинфекционный. М., Практическая медицина, 2008.
  2. Егорова Н.Б., Ефремова В.Н., Курбатова Е.А., Кузьмина Л.А. Итоги экспериментального и клинического изучения поликомпонентной вакцины из антигенов условно патогенных микроорганизмов. Журн. микробиол. 1997, 6: 96-101.
  3. Курбатова Е.А. Разработка поликомпонентной вакцины из антигенов условно-патогенных микроорганизмов (Экспериментальное и клинико-иммунологическое исследование). Автореф. дисс. д-ра мед. наук. М., 1997.
  4. Меджитов Р., Джаневей Ч. Врожденный иммунитет. Казанский мед. журн. 2005, LXXXV (3): 161-167.
  5. Пинегин Б.В., Андронова Т. М., Швецов М.Ю. Ликопид. Современный подход к профилактике и лечению иммунодефицитных состояний. М., Мед. книга, 2004.
  6. Семенов Б.Ф., Зверев В.В. Концепция создания быстрой иммунологической защиты от патогенов. Журн. микробиол. 2007, 4: 93-100.
  7. Culter C.W., Jotwani R. Dendritic cells at the oral mucosal interface. J. Dent. Res. 2006, 85 (8): 678-689.
  8. Harris G., KuoLee R., Chen W. Role of Toll-like receptors in health and diseases of gastrointestinal tract. World J. Gastroenterol. 2006, 12 (14): 2149-2160.
  9. Maitra R., Porter M.A., Huang S., Gilmour B.P. Inhibition of NFkappa B by the natural product withaferin a in cellular models of cystic fibrosis inflammation. J. Inflamm. 2009, 6 (1): 15.
  10. Porrett P.M., Yuan X., La Rosa D.F. et al. Mechanisms underlying blockade of allograft acceptance by TLR ligands. J. Immunol. 2008, 181 (3): 1692-1699.
  11. Romange F. Current and future drugs targeting one class of immunity receptors: the Toll-like. Drug Dis. Today. 2007, 12 (1/2): 80-87.
  12. Wolska A., Lech-Maranda E., Robak T. Toll-like receptors and their role in hematologic malignancies. Curr. Mol. Med. 2009, 9 (3): 324-335.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2010 Akhmatova N.K., Egorova N.B., Akhmatov E.A., Kurbatova E.A., Semenova I.B., Chertov I.V., Semenov B.F., Zverev V.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies